Nanomaterials provide a new strategy for aged patients with tumor. (IMAGE)

Tsinghua University Press

Nanomaterials provide a new strategy for aged patients with tumor.

Caption

Current preclinical drug trials fail to fully account for the profound impact of immunosenescence on therapeutic efficacy-especially in immune-dependent cancer immunotherapy. Nanomedicine, integrating nanotechnology and medicine, offers a transformative solution by leveraging precise targeting and multifunctional design to overcome the barriers imposed by an aging immune system.

Credit

Nano Research, Tsinghua University Press

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.